secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK:        0001513525
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001213900-25-002855
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adial Pharmaceuticals updates business development presentation for upcoming meetings
--------------------------------------------------------------------------------

- Company will hold business development meetings over the next several weeks.
- Updated business development presentation furnished as Exhibit 99.1.
- Presentation includes forward-looking statements under safe harbor provisions.
- No specific financial data, milestones, or material changes disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513525/000121390025002855/0001213900-25-002855-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513525/000121390025002855/ea0227475-8k_adial.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-002855

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer